Brief: Intelligent Bio Solutions Announces Positive Results Of PK Study, A Key Milestone On Path To FDA 510(K) Submission
13/11/2024 13:35
Nov 13 (Reuters) - Intelligent Bio Solutions Inc
INBS.O :
* INTELLIGENT BIO SOLUTIONS ANNOUNCES POSITIVE RESULTS OF PK
STUDY, A KEY MILESTONE ON PATH TO FDA 510(K) SUBMISSION
* INTELLIGENT BIO SOLUTIONS INC - FDA 510(K) CLEARANCE COULD
INTRODUCE INBS TECHNOLOGY TO US IN 2025
Source text: ID:nGNXbyZkSy
Further company coverage: INBS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study